Sarah Bennett
Combination vaccines, or administering multiple vaccines simultaneously, has been the subject of several safety studies. The safety, efficacy, and immunogenicity of combination vaccines are influenced by interactions between antigens and other components. While some studies suggest that combining vaccines do not increase adverse events, others indicate a small increased risk of febrile seizures in certain cases. Combination vaccines aim to reduce distress and improve immunization coverage, but the increasing number of antigens may pose challenges. The development of new combination vaccines should include clinical studies to ensure safety and efficacy. Overall, the weight of evidence suggests that combination vaccines are generally safe and effective, but ongoing surveillance and further studies are necessary to monitor for any adverse effects.
Explore related products
What You'll Learn
Combination vaccines are safe and effective
Vaccines are the best defence against infections that may have serious complications such as pneumonia, meningitis, cancer, and even death. The use of combination vaccines reduces distress to the recipients and is likely to increase uptake rates. Many combinations are as efficacious as the separate vaccines, but the increasing number of antigens could theoretically pose problems in terms of reduced immunogenicity or increased reactogenicity.
The development plan for new combination vaccines should include clinical studies designed to provide an adequate safety database to support licensure. Randomized studies should compare the safety of the combination vaccine with the separately administered components. Comparative immunogenicity data may provide a sufficient basis to support efficacy, precluding the need for a large efficacy study.
The World Health Organization (WHO) states that "licensed combination vaccines are just as safe and effective as the single-disease vaccines". The U.S. Centers for Disease Control and Prevention (CDC) states that "before a combination vaccine is approved for use, it goes through careful testing to make sure the combination vaccine is as safe and effective as each of the individual vaccines given separately".
However, in contrast to the WHO and U.S. CDC statements, some studies have shown that combined vaccines are not always as safe and effective as the individual vaccines. For example, a study in The Lancet noted that the risk of febrile seizures is increased following administration of DTP-based combined vaccines. Similarly, a large Danish cohort study also showed an increased risk of febrile seizures following DTaP–IPV–Hib vaccination. Retrospective cohort studies using the VSD found no increase in risk of acute adverse events or adverse birth outcomes among those vaccinated with Tdap or influenza vaccines during pregnancy.
Vaccine Route and Site: What's the Right Combo?
You may want to see also
Explore related products
They reduce distress and increase uptake rates
Combination vaccines reduce distress by minimising the number of injections required. This is achieved by combining as many antigens as possible into as few injections as possible. This approach reduces the distress experienced by recipients and their parents, who generally have fewer concerns about multiple injections than health professionals.
For instance, two Swedish vaccine trials found that adding an efficacious whole-cell pertussis (wP) component to diphtheria and tetanus vaccines increased the geometrical mean titre of diphtheria antitoxin in the recipients. This combination vaccine, known as DTwP, can be further combined with the Hib vaccine with no clinically significant loss in immunogenicity.
Combination vaccines are also likely to increase uptake rates. This is partly due to the reduced distress associated with fewer injections, but also because of the convenience of receiving multiple vaccines in a single injection. This is particularly beneficial for children, as the routine childhood vaccination programme in the United Kingdom includes ten vaccines with multiple doses.
Furthermore, combination vaccines do not increase the overall rate of adverse events. In some cases, such as with the DTaP vaccine, the rates of adverse events are lower when compared to administering the component vaccines separately. This was demonstrated in a study by Schmitt et al., where no difference was found in adverse events when children received DTaP-HBV-IPV-Hib as one injection compared to receiving the same antigens with the Hib given at a different site.
While combination vaccines offer these benefits, it is important to monitor their clinical efficacy and adverse effects through good post-marketing surveillance. This is because the increasing number of antigens in combination vaccines could theoretically lead to reduced immunogenicity or increased reactogenicity.
Fetal Cells in MMR Vaccines: Abortion's Dark Legacy
You may want to see also
Explore related products
Combining vaccines does not increase adverse events
Combining vaccines does not increase the overall rate of adverse events. In fact, with some combinations, such as DTaP, the rates are lower than when the component vaccines are given separately. In a study, Schmitt et al. compared antibody responses in children receiving DTaP-HBV-IPV-Hib as one injection with children receiving the same antigens but with the Hib given at a different site. No difference was found in adverse events associated with the different regimens.
Some parents are concerned that multiple antigens may overload an infant's immune system. However, a recent review emphasised the capacity of the immune system to respond effectively to numerous simultaneous antigens. Using data linkage, Miller et al. found no evidence for an increase in hospital admissions for serious bacterial infections following MMR vaccination.
Two methodologically sound, controlled epidemiological studies found no association between autism spectrum disorder (ASD) and simultaneous vaccination with multiple vaccines. A 2002 report by the Institute of Medicine (IOM), now called the National Academy of Medicine (NAM), entitled "Immunization Safety Review: Multiple Immunizations and Immune Dysfunction", found that the evidence favours rejection of a causal relationship between multiple immunizations and an increased risk for infections and type I diabetes.
A randomized trial in France and Belgium during the 2014–2015 influenza season found no difference in rates of symptoms among older adults when comparing the co-administration of IIV4 and PPV23 with separate administration, except for injection site pain, which occurred more frequently in the co-administration group. A 2016 report summarizing ten phase 3 and 4 studies found no impact on vaccine reactogenicity or safety when co-administering routine vaccines with MenACWY-CRM.
While it is true that certain combination vaccines or simultaneous administration of vaccines that are known to cause fever can rarely cause febrile seizures in infants and young children, this risk is not beyond the risk presented by individually administered vaccines.
US-Made Vaccines: Where Are They Produced?
You may want to see also
Safety studies are conducted for licensure
Safety studies are an integral part of the licensure process for combination vaccines, and various approaches are employed to evaluate their safety and efficacy.
The development plan for new combination vaccines should include well-designed clinical studies to generate a robust safety database and efficacy data to support licensure. Randomized controlled trials are considered ideal for comparing the safety profile of the combination vaccine with its individual components or already licensed combinations. For instance, Schmitt et al. compared the safety of administering DTaP-HBV-IPV-Hib as a single injection versus separate injections and found no significant difference in adverse events between the two regimens.
In certain cases, comparative immunogenicity data may suffice for efficacy evaluation, negating the need for large-scale efficacy studies. However, if such efficacy studies are not conducted, it is crucial to perform a comparative safety study with an appropriate sample size to assess less common adverse events adequately. Large safety trials may employ a simplified design, focusing on detailed assessments of common adverse events in a subset of participants.
Phase I to III clinical trials play a pivotal role in monitoring and safety assessment during the development of combination vaccines. These trials help evaluate the safety and immunogenicity of the vaccines, ensuring they are safe for human use.
Additionally, post-marketing surveillance is vital for ongoing monitoring of both the clinical efficacy of combination vaccines and any adverse effects. This continuous evaluation ensures that any safety concerns are promptly identified and addressed, contributing to the overall safety profile of the vaccine.
While combination vaccines have been shown to be generally safe and effective, some studies have indicated specific adverse events associated with certain combinations. For example, an increased risk of febrile seizures has been linked to DTP-based and DTaP–IPV–Hib combination vaccines. Moreover, studies in Germany and Italy reported an elevated rate of sudden unexpected deaths following the administration of the combined DTaP–HBV–Hib–IPV vaccine. These findings underscore the importance of rigorous safety studies and ongoing surveillance to ensure the safety of combination vaccines.
Baby Got Fever Post-Vaccination? Here's What to Do
You may want to see also
Multiple vaccinations are safe for children
A number of studies have been conducted to examine the effects of administering various vaccine combinations. The recommended vaccines have been shown to be as effective in combination as they are individually. In some cases, certain combinations of vaccines given together can cause fever and, occasionally, febrile seizures. However, these reactions are temporary and do not cause any lasting harm.
The safety, efficacy, and immunogenicity of a combined vaccine may be influenced by interactions between antigens and other components such as adjuvants and stabilisers. Nevertheless, combining vaccines into a single product does not increase the overall rate of adverse events, and in some combinations, such as DTaP, the rates are lower than when the component vaccines are administered separately.
Multiple studies have confirmed the safety of administering multiple vaccines simultaneously. Two methodologically sound, controlled epidemiological studies found no association between autism spectrum disorder (ASD) and simultaneous vaccination with multiple vaccines. Additionally, a 2002 report by the Institute of Medicine (now the National Academy of Medicine) concluded that the evidence favours rejecting a causal relationship between multiple immunisations and an increased risk of infections or type I diabetes.
Furthermore, the use of combination vaccines reduces distress for recipients and is likely to increase uptake rates. While the increasing number of antigens could theoretically pose challenges in terms of reduced immunogenicity or increased reactogenicity, good post-marketing surveillance is crucial for monitoring both the clinical efficacy of combination vaccines and any adverse effects.
Hepatitis A & B: Vaccination Options and Availability
You may want to see also
Frequently asked questions
Yes, combination vaccines are safe for children. They reduce distress to the recipients and are likely to increase uptake rates. Many combinations are as efficacious as the separate vaccines. The U.S. CDC states that before a combination vaccine is approved for use, it goes through careful testing to ensure the combination vaccine is as safe and effective as each of the individual vaccines given separately.
Combining vaccines into one product does not increase the overall rate of adverse events. However, certain combination vaccines or simultaneous administration of vaccines that are known to cause fever can rarely cause febrile seizures in infants and young children. A 2002 report by the Institute of Medicine (IOM) found that the evidence favors rejection of a causal relationship between multiple immunizations and an increased risk for infections and type I diabetes.
Examples of combination vaccines are: DTap (diphtheria, tetanus, pertussis), trivalent IPV (three strains of inactivated polio vaccine), MMR (measles, mumps, rubella), DTap-Hib, and Hib-Hep B.
